MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Use with caution

Zopiclone 3.75mg tablets (Ria Generics Ltd)

Explore other Zopiclone formulations Explore other Zopiclone 3.75mg tablets suppliers

Stability Notes

Protect from light. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Zimovane LS 3.75mg tablets (Sanofi) and Zopiclone 3.75mg tablets (Accord Healthcare Ltd).

Use with caution

Zopiclone 3.75mg tablets (Sigma Pharmaceuticals Plc)

Explore other Zopiclone formulations Explore other Zopiclone 3.75mg tablets suppliers

Stability Notes

Protect from light. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Zimovane LS 3.75mg tablets (Sanofi) and Zopiclone 3.75mg tablets (Accord Healthcare Ltd).

Use with caution

Zopiclone 3.75mg tablets (Teva UK Ltd)

Explore other Zopiclone formulations Explore other Zopiclone 3.75mg tablets suppliers

Stability Notes

Protect from light. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Zimovane LS 3.75mg tablets (Sanofi) and Zopiclone 3.75mg tablets (Accord Healthcare Ltd).

Use with caution

Zopiclone 7.5mg tablets (A A H Pharmaceuticals Ltd)

Explore other Zopiclone formulations Explore other Zopiclone 7.5mg tablets suppliers

Stability Notes

Protect from light. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Zimovane 7.5mg tablets (Sanofi) and Zopiclone 7.5mg tablets (Accord Healthcare Ltd).

Use with caution

Zopiclone 7.5mg tablets (Accord-UK Ltd)

Explore other Zopiclone formulations Explore other Zopiclone 7.5mg tablets suppliers

Stability Notes

Protect from light. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Zimovane 7.5mg tablets (Sanofi) and Zopiclone 7.5mg tablets (Accord Healthcare Ltd).

Use with caution

Zopiclone 7.5mg tablets (Alliance Healthcare (Distribution) Ltd)

Explore other Zopiclone formulations Explore other Zopiclone 7.5mg tablets suppliers

Stability Notes

Protect from light. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Zimovane 7.5mg tablets (Sanofi) and Zopiclone 7.5mg tablets (Accord Healthcare Ltd).

Use with caution

Zopiclone 7.5mg tablets (Almus Pharmaceuticals Ltd)

Explore other Zopiclone formulations Explore other Zopiclone 7.5mg tablets suppliers

Stability Notes

Protect from light. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Zimovane 7.5mg tablets (Sanofi) and Zopiclone 7.5mg tablets (Accord Healthcare Ltd).

Use with caution

Zopiclone 7.5mg tablets (Bristol Laboratories Ltd)

Explore other Zopiclone formulations Explore other Zopiclone 7.5mg tablets suppliers

Stability Notes

Protect from light. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Zimovane 7.5mg tablets (Sanofi) and Zopiclone 7.5mg tablets (Accord Healthcare Ltd).

Use with caution

Zopiclone 7.5mg tablets (Crescent Pharma Ltd)

Explore other Zopiclone formulations Explore other Zopiclone 7.5mg tablets suppliers

Stability Notes

Protect from light. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Zimovane 7.5mg tablets (Sanofi) and Zopiclone 7.5mg tablets (Accord Healthcare Ltd).

Use with caution

Zopiclone 7.5mg tablets (Flamingo Pharma (UK) Ltd)

Explore other Zopiclone formulations Explore other Zopiclone 7.5mg tablets suppliers

Stability Notes

Protect from light. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Zimovane 7.5mg tablets (Sanofi) and Zopiclone 7.5mg tablets (Accord Healthcare Ltd).

Use with caution

Zopiclone 7.5mg tablets (Medihealth (Northern) Ltd)

Explore other Zopiclone formulations Explore other Zopiclone 7.5mg tablets suppliers

Stability Notes

Protect from light. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Zimovane 7.5mg tablets (Sanofi) and Zopiclone 7.5mg tablets (Accord Healthcare Ltd).

Use with caution

Zopiclone 7.5mg tablets (Milpharm Ltd)

Explore other Zopiclone formulations Explore other Zopiclone 7.5mg tablets suppliers

Stability Notes

Protect from light. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Zimovane 7.5mg tablets (Sanofi) and Zopiclone 7.5mg tablets (Accord Healthcare Ltd).

Use with caution

Zopiclone 7.5mg tablets (Novumgen Ltd)

Explore other Zopiclone formulations Explore other Zopiclone 7.5mg tablets suppliers

Stability Notes

Protect from light. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Zimovane 7.5mg tablets (Sanofi) and Zopiclone 7.5mg tablets (Accord Healthcare Ltd).

Use with caution

Zopiclone 7.5mg tablets (Phoenix Healthcare Distribution Ltd)

Explore other Zopiclone formulations Explore other Zopiclone 7.5mg tablets suppliers

Stability Notes

Protect from light. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Zimovane 7.5mg tablets (Sanofi) and Zopiclone 7.5mg tablets (Accord Healthcare Ltd).

Use with caution

Zopiclone 7.5mg tablets (Ria Generics Ltd)

Explore other Zopiclone formulations Explore other Zopiclone 7.5mg tablets suppliers

Stability Notes

Protect from light. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Zimovane 7.5mg tablets (Sanofi) and Zopiclone 7.5mg tablets (Accord Healthcare Ltd).

Print this list

Compatible

Medicines suitable for use in MCAs, although use is likely to be off-label.  Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed).  Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices.  Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Use with caution

There are concerns about stability and/or there is a lack of stability data available. These medicines can theoretically be used in MCAs, although use is likely to be off-label.  Mitigation measures may need to be considered.  Keep medicines in MCAs for the shortest time necessary.  Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed). Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices. Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Incompatible

Medicines under this category are not suitable for use in MCAs.

No Stability Information

These medicines have not been reviewed by SPS.